Michel Farnier
0000-0002-0349-7978
Publication & Citation Trends
Publications
0 total
Higher EPA levels and EPA/DHA Ratios Are associated with Lower Cardiovascular Mortality Post-Myocardial Infarction.
Cited by 1
Semantic Scholar
Optimizing oral low-density lipoprotein cholesterol-lowering therapy in statin-intolerant patients: A simulation study in France.
Cited by 1
Semantic Scholar
High Adherence to High-Intensity Statins after Acute Myocardial Infarction: the "PACMAN Pathway".
Cited by 0
Semantic Scholar
Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction.
Cited by 3
Semantic Scholar
Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction OA
Cited by 1
Semantic Scholar
Management of lipid variables in primary cardiovascular prevention: A position paper from the Heart, Vessels and Metabolism Group of the French Society of Cardiology.
Cited by 1
Semantic Scholar
Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia
Cited by 15
Semantic Scholar
Is there still a place for fenofibrate-statin combination therapy? OA
Cited by 2
Semantic Scholar
Research Topics
Lipoproteins and Cardiovascular Health
(285)
Diabetes, Cardiovascular Risks, and Lipoproteins
(91)
Cancer, Lipids, and Metabolism
(83)
Pharmaceutical Economics and Policy
(66)
Health Systems, Economic Evaluations, Quality of Life
(55)
Affiliations
University of Pisa
Merck & Co., Inc., Rahway, NJ, USA (United States)
Centre National de la Recherche Scientifique
Amgen (United States)
Dornier Flugzeugwerke (Germany)